RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ETNB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for 89bio, Inc. stock after losing 0.234%
(Updated on Apr 30, 2024)

Sell candidate since Apr 05, 2024 Loss -20.91% PDF

The 89bio, Inc. stock price fell by -0.234% on the last day (Tuesday, 30th Apr 2024) from $8.53 to $8.51. During the last trading day the stock fluctuated 4.16% from a day low at $8.42 to a day high of $8.77. The price has fallen in 6 of the last 10 days and is down by -9.18% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 519 thousand shares were bought and sold for approximately $4.42 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.21 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.19% during the next 3 months and, with a 90% probability hold a price between $7.79 and $12.61 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ETNB Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 3.15%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The 89bio, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.62 and $10.53. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for 89bio, Inc. stock

89bio, Inc. finds support from accumulated volume at $8.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.350 between high and low, or 4.16%. For the last week, the stock has had daily average volatility of 4.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ETNB) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect 89bio, Inc. to open at $8.57, and during the day (based on 14 day Average True Range), to move between $7.96 and $9.06, which gives a possible trading interval of +/-$0.550 (+/-6.46%) up or down from last closing price. If 89bio, Inc. takes out the full calculated possible swing range there will be an estimated 12.93% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.45 (0.71%) than the resistance at $8.85 (4.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

89bio, Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.480. We will update the financials statements for 89bio, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.99% in the first trading day after earnings release.

Is 89bio, Inc. stock A Buy?

89bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.277 Sell Candidate Unchanged

Predicted Opening Price for 89bio, Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$8.57 ( 0.666%) $8.51

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ETNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.92 4.78 %
R2 8.78 3.21 %
R1 8.70 2.24 %
Current price: 8.51
Support S1 8.43 -0.91 %
S2 8.35 -1.88 %
S3 8.22 -3.45 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.80 15.16 %
R2 9.38 10.22 %
R1 8.85 4.00 %
Current price 8.51
Support S1 8.45 -0.705%
S2 8.34 -2.00%
S3 8.13 -4.47%

FAQ

What is the symbol for 89bio, Inc. Stock and on which exchange is it traded?
The symbol for 89bio, Inc. is ETNB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell 89bio, Inc. Stock?
89bio, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy 89bio, Inc. Stock?
89bio, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy 89bio, Inc. Stock.

What's the current price of 89bio, Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an 89bio, Inc. (ETNB) share was $8.51.

What is the 52-week high and low for 89bio, Inc. Stock?
The 52-week high for 89bio, Inc. Stock is $22.93 and the 52-week low is $6.58.

What is the market capitalization of 89bio, Inc. Stock?
As of the Apr 30, 2024, the market capitalization of 89bio, Inc. is 797.565M.

When is the next earnings date for 89bio, Inc.?
The upcoming earnings date for 89bio, Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About 89bio, Inc.

89bio. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorpor... ETNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT